• Home
• cancer treatment
• Clinical trials present a new approach using immunotherapy

Clinical trials present a new approach using immunotherapy

4.7 (526) · $ 15.99 · In stock

After 40 years of treating metastatic bladder cancer with chemotherapy as a primary treatment, scientists now present a new approach using immunotherapy combinations. The results of two studies have been presented at the European Society for Medical Oncology (ESMO) conference in Madrid. The outcomes of these studies could revolutionize the landscape of bladder cancer treatment.

Tumor Microenvironment Program - USC Norris Comprehensive Cancer Center

Immunotherapy: Pushing the Frontier of Cancer Medicine

Investigating the Side Effects of Cancer Immunotherapy - NCI

Design considerations for early-phase clinical trials of immune-oncology agents, Journal for ImmunoTherapy of Cancer

Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma

CRISPR Clinical Trials: A 2021 Update - Innovative Genomics Institute (IGI)

PDF) Predicting analysis times in randomized clinical trials with cancer immunotherapy

SITC Cancer Immunotherapy CONNECT - Society for Immunotherapy of Cancer (SITC)

Immunotherapy approaches for hematological cancers - ScienceDirect